AInvest★★★★★3-DAY FREE
Catch pre-market movers with AI signals.
Claim Trial
LYRA(Quitar la ciudad)
Lyra Therapeutics·NASDAQ
--
--(--)
Lyra Therapeutics (LYRA) Financial Statements
Lyra Therapeutics (LYRA) Cash Flow Statement
During Q3 2025, Lyra Therapeutics (LYRA) generated -7.36M in cash flow from operating activities, 0 from investing activities, and -368.00K from financing activities. Click to view the cash flow statement and track how funds are moving through the company.
Cash Flow
Q1,2019 | Q1,2020 | Q1,2021 | Q1,2022 | Q1,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | TTM |
|---|
Start Date | Jan 1, 2019 | Jan 1, 2020 | Jan 1, 2021 | Jan 1, 2022 | Jan 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | -- |
End Date | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Net Cash Flows from Operating Activities | -3.00M -- | -4.02M -33.68% | -7.59M -88.95% | -11.90M -56.85% | -15.85M -33.14% | -19.06M -- | -22.45M -41.67% | -19.98M -- | -16.22M -- | -11.35M +40.43% | -8.84M +60.62% | -6.59M +67.02% | -7.36M +54.63% | -34.15M -- |
Net Income | -- -- | -- -- | -- -- | -- -- | -- -- | -15.16M -- | -22.45M -- | -48.13M -- | -11.87M -- | -10.98M +27.56% | -8.55M +61.93% | -7.44M +84.55% | -5.98M +49.60% | -32.95M -- |
Depreciation and Amortization | 8.00K -- | 8.00K -- | 70.00K +775.00% | 280.00K +300.00% | 284.00K +1.43% | 85.00K -- | 136.00K -52.11% | 145.00K -- | 39.00K -- | 151.00K +77.65% | 128.00K -5.88% | 127.00K -12.41% | 104.00K +166.67% | 510.00K -- |
Stock-based Compensation | -- -- | -- -- | -- -- | -- -- | -- -- | 1.48M -- | 2.16M -- | 1.12M -- | 1.49M -- | 1.94M +30.84% | 825.00K -61.84% | 914.00K -18.68% | 34.00K -97.72% | 3.71M -- |
Impairment of Assets | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 24.72M -- | 0 -- | 0 -- | -- -- | 0 -100.00% | 0 -- | -- -- |
Change in Working Capital | -11.00K -- | 450.00K +4190.91% | 530.00K +17.78% | -1.12M -310.94% | -763.00K +31.75% | 756.00K -- | -544.00K +28.70% | 1.65M -- | -5.82M -- | -2.98M -494.05% | -2.03M -273.16% | -970.00K -158.93% | -2.30M +60.53% | -8.28M -- |
Change in Accounts Payable | -- -- | -- -- | -- -- | -- -- | -- -- | -3.54M -- | -560.00K -- | 2.38M -- | -2.59M -- | -1.11M +68.51% | -454.00K +18.93% | -45.00K -101.89% | -120.00K +95.37% | -1.73M -- |
Change in Deferred Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -146.00K -- | -532.00K -- | -598.00K -- | -195.00K -- | -209.00K -43.15% | -183.00K +65.60% | -183.00K +69.40% | -25.00K +87.18% | -600.00K -- |
Change in Other Working Capital | -- -- | -- -- | -- -- | -- -- | -- -- | 4.44M -- | 548.00K -- | -134.00K -- | -3.04M -- | -1.66M -137.35% | -1.39M -354.20% | -742.00K -453.73% | -2.15M +29.06% | -5.95M -- |
Other Non-cash Adjustments | -- -- | -- -- | -- -- | -- -- | -- -- | -6.22M -- | -1.76M -- | 516.00K -- | -58.00K -- | 516.00K +108.29% | 782.00K +144.51% | 776.00K +50.39% | 783.00K +1450.00% | 2.86M -- |
Net Cash Flows from Investing Activities | -52.00K -- | -8.00K +84.62% | -1.16M -14400.00% | -93.00K +91.98% | 5.32M +5815.05% | -2.36M -- | 7.86M +47.83% | 36.18M -- | 8.14M -- | 28.13M +1292.50% | 0 -100.00% | -2.00K -100.01% | 0 -100.00% | 28.13M -- |
Change in PPE and Intangible Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -787.00K -- | -2.15M -- | -196.00K -- | -51.00K -- | 58.00K +107.37% | 0 +100.00% | -2.00K +98.98% | 0 +100.00% | 56.00K -- |
Disposal of PPE and Intangible Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | 18.00K -- | 0 -- | -- -- |
Purchase of PPE and Intangible Assets | 52.00K -- | 8.00K -84.62% | 1.16M +14400.00% | 93.00K -91.98% | 45.00K -51.61% | 787.00K -- | 2.15M +4675.56% | 196.00K -- | 51.00K -- | -58.00K -107.37% | 0 -100.00% | 20.00K -89.80% | 0 -100.00% | -38.00K -- |
Change in Investments | -- -- | -- -- | -- -- | -- -- | -- -- | -1.57M -- | 10.01M -- | 36.37M -- | 8.19M -- | 28.07M +1885.81% | 0 -100.00% | 0 -100.00% | 0 -100.00% | 28.07M -- |
Decrease in Investments | -- -- | -- -- | -- -- | -- -- | -- -- | 48.09M -- | 30.53M -- | 50.99M -- | 21.00M -- | 28.07M -41.62% | 0 -100.00% | 0 -100.00% | 0 -100.00% | 28.07M -- |
Increase in Investments | -- -- | -- -- | -- -- | -- -- | 4.44M -- | 49.66M -- | 20.52M +362.27% | 14.62M -- | 12.81M -- | 0 -100.00% | 0 -100.00% | 0 -100.00% | 0 -100.00% | -- -- |
Net Cash Flows from Financing Activities | -- -- | 29.46M -- | 262.00K -99.11% | 6.00K -97.71% | 4.00K -33.33% | 18.92M -- | 8.64M +216000.00% | -89.00K -- | -23.00K -- | -1.00K -100.01% | 0 -100.00% | 4.64M +5314.61% | -368.00K -1500.00% | 4.27M -- |
Change in Capital Stock | -- -- | -- -- | 262.00K -- | -- -- | -- -- | 19.24M -- | 8.81M -- | 9.00K -- | 0 -- | -1.00K -100.01% | 0 -100.00% | 5.00M +55444.44% | 0 -- | 5.00M -- |
Increase in Capital Stock | -- -- | -- -- | 262.00K -- | -- -- | -- -- | 19.24M -- | 8.81M -- | 9.00K -- | 0 -- | -1.00K -100.01% | 0 -100.00% | 5.00M +55444.44% | 0 -- | 5.00M -- |
Other Financing Activities | -- -- | -- -- | -- -- | -- -- | -- -- | -322.00K -- | -169.00K -- | -98.00K -- | -23.00K -- | 0 +100.00% | 0 +100.00% | -358.00K -265.31% | -368.00K -1500.00% | -726.00K -- |
Net Increase in Cash and Cash Equivalents | -3.06M -- | 25.44M +932.16% | -8.49M -133.37% | -11.99M -41.28% | -10.53M +12.18% | -2.50M -- | -5.95M +43.46% | 16.11M -- | -8.11M -- | 16.78M +771.93% | -8.84M -48.51% | -1.95M -112.11% | -7.73M +4.64% | -1.74M -- |
Cash and Cash Equivalents at Beginning of Period | 24.22M -- | 10.14M -58.14% | 74.92M +639.09% | 46.08M -38.50% | 33.94M -26.33% | 26.24M -- | 23.75M -30.04% | 17.79M -- | 33.90M -- | 25.79M -1.71% | 42.57M +79.28% | 33.73M +89.58% | 31.78M -6.25% | 133.87M -- |
Cash and Cash Equivalents at End of Period | 21.16M -- | 35.58M +68.13% | 66.43M +86.74% | 34.08M -48.69% | 23.41M -31.31% | 23.75M -- | 17.79M -24.01% | 33.90M -- | 25.79M -- | 42.57M +79.28% | 33.73M +89.58% | 31.78M -6.25% | 24.05M -6.76% | 132.12M -- |
You can ask Aime
No Data
